ICUI / ICU Medical, Inc. (ICUI) CEO Vivek Jain on Q2 2022 Results - Earnings Call Transcript

The Plum Duo infusion pump represents the latest addition to ICU Medical's (ICUI) advanced lineup of infusion devices. more_horizontal

ICU Medical's deal with Smiths Medical is underperforming, following a previous troubled deal with Hospira Infusion Systems. Shares have fallen by 50% more_horizontal

ICU Medical (ICUI) came out with quarterly earnings of $1.88 per share, beating the Zacks Consensus Estimate of $1.55 per share. This compares to earn more_horizontal

ICU Medical, Inc. (NASDAQ:ICUI ) Q1 2023 Earnings Conference Call May 8, 2023 4:30 PM ET Company Participants John Mills - Managing Partner, ICR, Inc. more_horizontal

ICU Medical (ICUI) came out with quarterly earnings of $1.74 per share, beating the Zacks Consensus Estimate of $1.38 per share. This compares to earn more_horizontal

ICU Medical, Inc. (NASDAQ:ICUI ) Q4 2022 Earnings Conference Call February 27, 2023 4:30 PM ET Company Participants John Mills - ICR Vivek Jain - Chai more_horizontal

ICU Medical (ICUI) delivered earnings and revenue surprises of 6.67% and 0.10%, respectively, for the quarter ended December 2022. Do the numbers hold more_horizontal

SAN CLEMENTE, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) --  ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innova more_horizontal